iBio (IBIO) EPS (Diluted) (2010 - 2026)

iBio (IBIO) EPS (Diluted) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - 0.00
2 Nanobiotix 1,933.35 Bn 1,933.29 Bn - -
3 Akari Therapeutics 1,063.56 Bn 1,063.56 Bn - 0.00
4 BeOne Medicines 468.54 Bn 463.75 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 123.45 Bn 116.20 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 70.42 Bn 61.67 Bn 3.31 Bn 6.75
7 Belite Bio 63.57 Bn 63.57 Bn - 0.00
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn 7.33
9 Alnylam Pharmaceuticals 37.75 Bn 34.74 Bn 959.66 Mn 1.49
10 iBio 167.44 Mn 167.44 Mn - -0.06

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.06
Dec 31, 2025 -0.09
Sep 30, 2025 -0.11
Jun 30, 2025 -0.48
Mar 31, 2025 -0.49
Dec 31, 2024 -0.48
Sep 30, 2024 -0.46
Jun 30, 2024 -1.18
Mar 31, 2024 -0.14
Dec 31, 2023 -2.01
Sep 30, 2023 -0.56
Jun 30, 2023 -1.80
Mar 31, 2023 -1.54
Dec 31, 2022 -46.88
Sep 30, 2022 -17.05
Jun 30, 2022 -39.11
Mar 31, 2022 -28.40
Dec 31, 2021 -27.41
Sep 30, 2021 -12.06
Jun 30, 2021 0.13